Featured

Positioning ORCA Minerals as a credible alternative in critical minerals biomining

How ZingPR helped Blue Evolution strategically launch ORCA Minerals, clearly communicating its groundbreaking biomining innovation, building investor confidence, and establishing market credibility.

Angiex initiates first-in-human trial of AGX101, a novel ADC targeting TM4SF1 to disrupt tumor blood supply

Angiex selected ZingPR to generate excitement and build momentum for the Phase 1 clinical trial of AGX101, a novel antibody-drug conjugate (ADC) designed to revolutionize cancer treatment by targeting tumor blood vessels. The campaign played a crucial role in communicating the potential of AGX101 to transform cancer treatment and attracting support for Angiex's mission.

Expanded Access Programs for ALS: how WideTrial took flight

WideTrial, a startup focused on expanded access programs (EAPs), partnered with ZingPR to announce its role in a major NIH-funded EAP for ALS. The challenge was to generate excitement while establishing credibility and navigating the constraints faced by many startups. How ZingPR helped WideTrial achieve significant media coverage in prominent publications.

The aging debate: why it matters (and how we made it matter more)

Recently, I had the chance to work on a fascinating project: promoting a debate on aging. Not your typical PR gig, right? But that's what I love about this field—the chance to work with innovative companies tackling big challenges. My goal was simple: make this debate unmissable. And more importantly, make it matter. Because the science behind it really matters.

ZingPR’s star newsmakers